@Enoch_Chang

GI Radiation Oncologist | MD Anderson Cancer Center

Joined October 2017
  • Tweets31
  • Following484
  • Followers304
1Media
Dr @Ansel_PhD at #ASTRO24 on how to better design a clinical trial. If we want our trials to succeed, we should carefully consider how to power them as control arm overperformance is highly prevalent and associated with lower odds of a positive primary endpoint.
2
8
1,309
Our @MDAndersonNews PGY4 resident @StephDudzinski presents study evaluating genomic&path features a/w outcome for SLN+ melanoma pts. No assoc btwn dz outcomes &TERT/ATRX or BRAF mutations but adverse path features=badness.Clinical trial ongoing.Fantastic work! #ASTRO24 @ashleighg
1
4
26
1,374
Promising initial results of IMMUNOCERV vaccine study in cervical cancer reported by ⁦@adam_grippin⁩ from ⁦@MDAndersonNews⁩. #endcancer #radonc
2
17
9
66
31,243
Remarkable innovation by another stellar resident @MDAndersonNews @BenjaminSchrank in @wenjiang_nano lab to enhance anti-tumor immunity through a novel macrophage targeting ADC!! @ACKoongMDPhD @ChelseaPinnix
3
5
24
1,569
Enoch Chang retweeted
Joe Y Chang@JoeChangMD1 Oct 2024
What are the biological mechanisms after SABR vs SABR plus IO in early stage NSCLC? Our talented resident @ASeoMDPhD presented different dynamic immunological cytokines profiles in our I-SABR randomized study @MDAndersonNews
7
1
23
2,136
Cullen would be so proud of you @Vince_BernPag You are a masterful science communicator just like he was. ❤️
Albert Koong, MD PhD@ACKoongMDPhD30 Sep 2024
Persister cells after neoadjuvant treatment for pancreatic cancer are enriched in genes involved in #ferroptosis and #cuproptosis. Fantastic translational study by ⁦@Vince_BernPag⁩ from ⁦@MDAndersonNews⁩. #ASTRO24 #endcancer #radonc
2
4
37
3,500
Congratulations to @MDAndersonNews #RadOnC resident @dr_p_carriere for an outstanding presentation on the 2ndary analysis of the 1,656 low risk prostate cancer pts enrolled on the CEASAR study. Job well done!
5
24
1,461
Thank you Dr. Gibbs for joining us here at @MDAndersonNews as a visiting professor! What a privilege to learn from such an inspiring trailblazer in the field
2
2
19
3,560
Truly honored to cap off the @AACR @ASCO Clinical Trial Workshop with the award for Most Innovative Protocol! Huge thank you to workshop faculty, many new friends, and leadership @MDAndersonNews for supporting this incredible week!
9
10
2
85
6,960
Congrats @ebludmir and @ChadTangMD! This @MDAndersonNews P2 randomized study shows PFS of 10.3 mo vs. 2.5 mo in #PancreasCancer pts with oligometastatic dz treated with metastasis-directed therapy+sys tx vs. sys tx alone. #radonc #endcancer ascopubs.org/doi/10.1200/JCO…

Addition of Metastasis-Directed Therapy to Systemic Therapy for Oligometastatic Pancreatic Ductal...

PURPOSEThe EXTEND trial tested the hypothesis that adding comprehensive metastasis-directed therapy (MDT) to chemotherapy would improve progression-free survival (PFS) over chemotherapy alone among...

ascopubs.org
7
39
3
115
18,863
Superstar⁩ #radonc resident, ⁦@lee_kamaria⁩, presents results of impact of mobile health technology on health outcomes in Sub-Saharan Africa. ⁦Data presented @MDAndersonNews⁩ and Cancer Diseases Hospital Joint Symposium in #Zambia.
4
19
1,113
Response-adapted RT led to complete resolution of orbital disease in 90% of patients @ChelseaPinnix @BouthainaDabaja #radonc jamanetwork.com/journals/jam…

Response-Adapted Ultralow-Dose Radiation Therapy for Orbital Indolent B-Cell Lymphoma

This nonrandomized controlled trial aims to determine if a response-adapted radiation therapy strategy will result in excellent disease outcomes while reducing orbital morbidity.

jamanetwork.com
3
11
926
Our new research highlights patient-level savings using the Mark Cuban Cost Plus Drug Company (MCCPDC) for purchasing generic drugs! This is the first study to quantify individual out-of-pocket savings by opting for MCCPDC over traditional insurance. jamanetwork.com/journals/jam…

Savings on Generic Drugs Through the Mark Cuban Cost Plus Drug Company

This economic evaluation estimates the out-of-pocket cost savings patients could achieve if generic drugs were purchased directly from the Mark Cuban Cost Plus Drug Company rather than using their...

jamanetwork.com
2
9
44
4,152
NEW: Response-adapted ultra-low-dose 4 Gy radiation as definitive therapy of gastric MALT #lymphoma: a single-centre, pilot trial @MDAndersonNews #lymsm thelancet.com/journals/lanha…
1
32
2
58
11,275
Congratulations @TaniguchiMD - I know how incredibly proud you are of this @TheLancetOncol study out today. Your paper made the cover highlight! This was Cullen’s baby from the very preclinical inception in his lab, and it breaks my heart that I can’t shake his hand in person. Stereotactic body radiotherapy with or without selective dismutase mimetic in #PancreaticCancer: an adaptive, randomised, double-blind, placebo-controlled, phase 1b/2 trial. thelancet.com/journals/lanon… Cc: @ACKoongMDPhD @PrajnanDasMD @colbertle @aguilera_md @DrShubhamPant @Vince_BernPag @ebludmir @eugenekoay
4
68
269
36,541
1/ 🔬🧫Tumoral lactic acid bacteria can rewire tumor metabolism and drive cancer treatment response. Our @cancercell paper is finally out #openaccess online! 🦠🔬 tinyurl.com/56puk8bx
10
23
3
79
20,995
Still reeling from the news about @TaniguchiMD . He was the best of us. A remarkable soul whose selflessness and kindness touched many, myself included. CT loved a good tweetorial, so in seeking words, I'll share memories of him. #RememberingCT
12
38
7
464
169,288
Enoch Chang retweeted
Joe Y Chang@JoeChangMD18 Jul 2023
Randomized study published in Lancet today, showing 62% EFS improvement with Nivo + SABR compared with SABR alone in early stage NSCLC. I-SABR is a promising TX option. awbs://authors.elsevier.com/c/1hRV5V-4XL3dJ @IASLC @MDAndersonNews @TheLancet @ACKoongMDPhD @StephenVLiu
17
184
20
453
117,310
Happy #MatchDay2021‼️ Congrats and welcome 🙌🏼 @MDAndersonNews #radonc #residency #Classof2026 to the #workfam ☢️💛 @ChelseaPinnix @DrEmmaHolliday @StephDudzinski @RKouzyMD @adam_grippin @Enoch_Chang @cd_fuller @TaniguchiMD – at Pearland, TX
11
8
9
146
Load more